TEMPO
Live / Allowed — Fourth extension granted (statement of use) (as of 13 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Sept 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97594642
- Mark type
- Word mark
- Filed
- 16 Sept 2022
- Published for opposition
- 25 Jun 2024
- Attorney of record
- Joyce Liou
Goods and services
- Class 005 — Pharmaceuticals: Biotechnologically-formed genes for use in the manufacture of pharmaceuticals and therapeutics
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals; manufacturing services for others in the field of pharmaceuticals
- Class 042 — Scientific and technological services: Research in the field of gene editing technology; research and development in the pharmaceutical and biotechnology fields; biotechnology research; Research and development in the pharmaceutical and biotechnology fields, namely, development of gene editing platforms for manufacturing pharmaceuticals
Owner
- Tune Therapeutics, Inc., Seattle, WA, US
- Tune Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 14 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jul 2026 — SOU EXTENSION 4 GRANTED
- 13 Jul 2026 — SOU EXTENSION 4 FILED
- 13 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 14 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Feb 2026 — SOU EXTENSION 3 GRANTED
- 05 Feb 2026 — SOU EXTENSION 3 FILED
- 05 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 24 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jul 2025 — SOU EXTENSION 2 GRANTED
- 23 Jul 2025 — SOU EXTENSION 2 FILED
- 23 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jan 2025 — SOU EXTENSION 1 GRANTED
- 21 Jan 2025 — SOU EXTENSION 1 FILED